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ABSTRACT: Members of the TNF and TNF 
receptor superfamilies acting by both forward and 
reverse signaling are increasingly recognized as major 
physiological regulators of axon growth and tissue 
innervation in development. Studies of the experimentally 
tractable superior cervical ganglion (SCG) neurons and 
their targets have shown that only TNF reverse signaling, 
not forward signaling, is a physiological regulator of 
sympathetic innervation. Here, we compared SCG 
neurons and their targets with prevertebral ganglion 
(PVG) neurons and their targets. Whereas all SCG 
targets were markedly hypoinnervated in both TNF-
deficient and TNFR1-deficient mice, PVG targets were 
not hypoinnervated in these mice and one PVG target, 
the spleen, was significantly hyperinnervated. These in 
vivo regional differences in innervation density were 
related to in vitro differences in the responses of SCG and 
PVG neurons to TNF reverse and forward signaling. 
Though TNF reverse signaling enhanced SCG axon 
growth, it did not affect PVG axon growth. Whereas 
activation of TNF forward signaling in PVG axons 
inhibited growth, TNF forward signaling could not be 
activated in SCG axons. These latter differences in the 
response of SCG and PVG axons to TNF forward 
signaling were related to TNFR1 expression, whereas 
PVG axons expressed TNFR1, SCG axons did not. These 
results show that both TNF reverse and forward signaling 
are physiological regulators of sympathetic innervation 
in different tissues. © 2019 The Authors. Developmental Neurobiology 
Published by Wiley Periodicals, Inc. Develop Neurobiol 79: 317–334, 2019
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INTRODUCTION
A variety of extracellular signals regulate the estab-
lishment of sympathetic innervation in the developing 
peripheral nervous system (Glebova and Ginty, 2005; 
Davies, 2009). The best understood of these is nerve 
growth factor (NGF), a secreted protein synthesized 
in tissues innervated by NGF-responsive neurons. 
NGF promotes the survival of developing sympathetic 
neurons, and the level of NGF synthesis in differ-
ent tissues regulates the number of neurons that in-
nervate these tissues by restricting the extent of cell 
death among the innervating neurons (Crowley et al., 
1994; Davies, 2003). Although NGF plays no role in 
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guiding sympathetic axons to their targets (Davies et 
al., 1987), it performs the crucial function of promot-
ing the growth and branching of sympathetic axons 
within most but not all targets of NGF-dependent 
sympathetic neurons (Glebova and Ginty, 2004).
A recently discovered target-derived signal that 
also promotes sympathetic axon growth and branch-
ing during the stage in development when sympathetic 
axons are ramifying in their targets is tumor necrosis 
factor receptor 1 (TNFR1). Studies supporting this 
idea were carried out on the experimentally tractable 
sympathetic neurons of the superior cervical ganglion 
(SCG) and their cranial innervation targets. TNFR1 is 
expressed by SCG targets and acts as a ligand for mem-
brane-integrated TNF expressed along SCG axons. 
TNFR1-activated TNF-mediated reverse signaling en-
hances SCG axon growth and branching in vitro during 
the stage when SCG axons are ramifying in their tar-
get tissues. Mice lacking either TNF or TNFR1 dis-
play greatly reduced sympathetic innervation density 
in vivo in all the SCG target tissues that were studied, 
but unlike NGF-deficient mice, these mice showed no 
deficits in sympathetic neuron number (Kisiswa et al., 
2013). While TNF-activated TNFR1-mediated forward 
signaling is able to reduce NGF-promoted axon growth 
from dissociated SCG neurons in vitro (Gutierrez et 
al, 2008; Kisiswa et al., 2013), the physiological sig-
nificance of this in vitro inhibitory response of SCG 
neurons to TNF has remained enigmatic because of the 
observed hypoinnervation phenotype of SCG targets in 
TNF-deficient and TNFR1-deficient mice.
Here, we have extended the in vivo analysis of TNF-
deficient and TNFR1-deficient mice to additional SCG 
targets and to prevertebral ganglion (PVG) targets, 
and have also studied the innervating populations of 
sympathetic neurons in vitro. We find that PVG tar-
gets do not exhibit the pronounced hypoinnervation 
phenotype of SCG targets observed in TNF-deficient 
and TNFR1-deficient mice and show that this in vivo 
difference can be accounted by differences in the re-
sponse of SCG and PVG neurons to TNF reverse and 
forward signaling in vitro. Our results demonstrate 
that distinctive signaling mechanisms in different 
populations of developing sympathetic neurons regu-
late and refine innervation in different tissues.
MATERIALS AND METHODS
Mice
Breeding and housing of mice (Mus musculus) was 
approved by the Cardiff University Ethical Review 
Board and was performed within the guidelines of the 
Home Office Animals (Scientific Procedures) Act, 
1986. Mice with null mutations in the Tnf gene (Korner 
et al., 1997) and the Tnfrsf1a gene (Pfeffer et al., 1993) 
in a C57BL/6 background were used. Tnf+/− mice were 
crossed to generate litters of Tnf+/+, Tnf+/−, and Tnf−/− 
pups and Tnfrsf1a+/− mice were crossed to generate 
litters of Tnfrsf1a+/+, Tnfrsf1a+/−, and Tnfrsf1a−/− pups. 
Dissociated cultures of SCG and PVG neurons were 
established from CD1 mice.
Quantification of the Sympathetic 
Innervation
A variety of tissues and organs (pineal gland, trachea, 
stomach, and spleen) were dissected and processed for 
visualization of sympathetic fibers by tyrosine hydrox-
ylase (TH) staining in either whole mount tissue prepa-
rations or immunolabeling-enabled three-dimensional 
imaging of solvent-cleared organs (iDISCO) or both. 
The whole mounts were carried out on tissue from 
P10 pups as described (Kisiswa et al., 2013) and the 
iDISCO preparations were carried out on tissue from 
P6 pups as described (Renier et al., 2014). Batches of 
tissue from littermates of all three genotypes of each 
mouse mutant were processed at the same time to en-
sure they were stained in an identical manner.
For the whole mount preparations, TH-positive fi-
bers were visualized by HRP-DAB staining and the 
specimens were imaged by phase contrast light mi-
croscopy (Nikon Diaphot). The same orientation and 
region was imaged for each organ using the following 
standard anatomical landmarks: pineal gland, TH-
positive axon bundles entering the gland; trachea, TH-
positive lateral axon bundles entering this structure; 
and spleen, TH-positive axon bundles accompanying 
the splenic arteries. Because it was difficult to maintain 
the structural integrity of the stomach after removal of 
milk, the most intensely innervated region closest to 
the lesser curvature was imaged. To compare the ex-
tent of sympathetic nerve branching, a modified line 
intercept method was used. Using ImageJ, a grid of 24 
squares (4 × 6 squares, 158 µm side length per square) 
was aligned in a standard orientation on images of 
the trachea, spleen, and stomach. For the smaller pi-
neal gland, the grid consisted of 6 × 6 squares of side 
length 50 μm per square. Fiber density was estimated 
using the formula πDI/2, where D is the interline inter-
val in microns (158 or 50) and I is the mean number of 
fiber bundles intersecting along one side of each grid 
square. The data are expressed as a percentage of the 
mean of the wild-type data. All imaging and quantifi-
cation was performed blind.
For iDISCO preparations, TH-positive fibers were 
fluorescently labeled using anti-TH antibody (1:200 
dilution of antibody AB152, Milliopore, Dundee, 
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UK) and Alexa Fluor 594 secondary antibody (1:300, 
Abcam). Using a 3D printed compartment, the stom-
ach and spleen were imaged in their entirety using 
inverted and confocal microscopy (Zeiss Axio Z2 
Imager and Zeiss LSM 710) and z-stacks were con-
structed. Fiji-Image J was used for semi-automated 
quantification of TH-immunoreactivity as a mea-
sure of sympathetic target organ innervation density. 
Images were converted to grayscale and the Feature 
Extraction (FeatureJ Hessian) tool was employed 
using the smallest eigenvalue of Hessian tensor with 
the smoothing scale set to 0.5. To ensure consistent 
analysis across all conditions, multiple images from 
all mice were initially analyzed to generate a uniform 
threshold value, which was applied to every image 
of the same organ analyzed followed by a user-de-
fined macro to provide quantitative measurement of 
TH-immunoreactivity within each target organ. The 
data are expressed as a percentage of the mean of the 
wild-type data. All imaging and quantification was 
performed blind.
Dissociated Neuron Culture
Dissected P0 and P5 SCG and prevertebral coeliac and 
superior mesenteric ganglia of CD1 mice were freed 
of adherent connective tissue using tungsten needles 
and were trypsinized and plated at very low density 
(~200 neurons per dish/well) in poly-ornithine and 
laminin-coated 35-mm tissue culture dishes (Greiner, 
Gloucestershire, UK) or 4-well dishes (Starlab, 
Milton Keynes, UK) in serum-free Hams F14 me-
dium (Davies et al., 1993) supplemented with 0.25% 
Albumax I (Invitrogen, Paisley, UK). Neurons were 
grown with either 10 ng/ml NGF or 10 ng/ml NGF 
plus either 30 ng/ml TNFR1-Fc (R&D Systems) or 
50 ng/ml recombinant mouse TNFα (R&D Systems) 
or 50 ng/ml TNFR2-Fc (R&D Systems). Analysis of 
the size and complexity of neurite arbors was carried 
out in 35 mm dishes 18 h after plating. The neurite ar-
bors were labeled by incubating the neurons with the 
fluorescent vital dye calcein-AM (1:1000, Invitrogen, 
Paisley, UK) at the end of the experiment. Images 
of neurite arbors were acquired by fluorescence mi-
croscopy and analyzed to obtain the Sholl profiles 
(Gutierrez and Davies, 2007).
Compartment Cultures
Either SCG or PVG neurons were plated at high density 
in one compartment (the soma compartment) of a two-
compartment microfluidic device (SND150, Xona mi-
crofludics, CA, USA) (Nagendran et al., 2018). At the 
time of plating, both compartments received NGF plus 
caspase inhibitor III (Merck, 218745-1MG). Either 
TNF or TNFR1-Fc was added to either the soma or 
axon compartment or neither compartment received 
any further treatment. After 18-h incubation, the soma 
that projected axons into the axon compartment was 
labeled by adding the fluorescent vital dye calcein-AM 
to the axon compartment. The dye was retrogradely 
transported and only labeled cell bodies that projected 
axons into the axon compartment, permitting normali-
zation of axon length to projecting soma number. Very 
similar high-density plating was used for all experi-
mental conditions. Axon length was quantified by a 
modification of a previously described method (Ronn 
et al., 2000). Briefly, using NIH ImageJ, a grid of ver-
tical lines was constructed with an interline interval 
of 200 μm. Total intersections between axons and the 
grid were counted and normalized against the num-
ber of labeled somas in the cell body compartment. 
Average axon length per projecting cell body was 
calculated using the formula L = DI/2, where L is the 
estimated length, D is the interline interval, and I is 
the average number of intersections per projecting cell 
body. Measurements were independently carried out 
in all fields along the microfluidic barrier.
Immunocytochemistry
The cultures were fixed in 4% paraformaldehyde (PFA) 
for 20 min and were washed with phosphate-buffered 
saline (PBS) before blocking nonspecific binding and 
permeablizing the cells with 5% bovine serum albu-
min (BSA) and 5% donkey serum plus 0.1% Triton 
X-100 (Sigma, Dorset, UK) in PBS for 1 h at room 
temperature. Neurons were incubated overnight with 
primary antibody in 1% blocking solution at 4oC. 
After washing with PBS, the cultures were incubated 
with the appropriate secondary antibody. The primary 
antibodies were: anti-βIII tubulin (1:1500, Abcam, 
ab41489), anti-TNF alpha (1:500, Abcam, ab34674), 
anti-TNFR1 (1:500, Abcam, ab19139), and anti-
TNFR2 (1:40, R&D, AF-426-PB). Secondary antibod-
ies were Alexa Fluor-conjugated anti-immunoglobulin 
from ThermoFisherScientific used at 1:500 (donkey 
anti-rabbit IgG Alexa Fluor 488, A21206; goat anti-
chicken Alexa Fluor 594, A11042; and donkey anti-
goat IgG Alexa Fluor 488, A11055). Images were 
obtained using a Zeiss LSM 710 confocal microscope.
Reverse Transcription-qPCR
The levels of Tnf and Tnfrsf1a mRNAs were quantified 
by RT-qPCR relative to a geometric mean of mRNAs for 
the house keeping enzymes glyceraldehyde phosphate 
dehydrogenase (GAPDH) and succinate dehydrogenase 
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(SDHA). Total RNA was extracted from whole SCG, 
celiac, and mesenteric ganglia at P0 with the RNeasy 
Mini extraction kit (Qiagen, Crawley, UK), and 5 μl 
was reverse transcribed for 1 h at 45°C using the 
AffinityScript kit (Agilent, Berkshire, UK) in a 25-µl 
reaction according to the manufacturer’s instructions. 
2 µl of cDNA was amplified in a 20-µl reaction volume 
using Brilliant III ultrafast qPCR master mix reagents 
(Agilent, Berkshire, UK). QPCR products were de-
tected using dual-labeled (FAM/BHQ1) hybridization 
probes specific to each of the cDNAs (MWG/Eurofins, 
Ebersberg, Germany). The PCR primers were: Tnf for-
ward, 5ʹ-TAC TTA GAC TTT GCG GAG-3ʹ and re-
verse, 5ʹ-AGA GTA AAG GGG TCA GAG-3ʹ; Tnfrsf1a 
forward, 5ʹ-TTC CCA GAA TTA CCT CAG-3ʹ and re-
verse, 5ʹ-AAC TGG TTC TCC TTA CAG-3ʹ; Gapdh 
forward, 5ʹ-GAG AAA CCT GCC AAG TAT G-3ʹ and 
reverse, 5ʹ-GGA GTT GCT GTT GAA GTC-3ʹ; Sdha 
forward, 5ʹ-GGA ACA CTC CAA AAA CAG-3ʹ and 
reverse, 5ʹ-CCA CAG CAT CAA ATT CAT-3ʹ. Dual-
labeled probes were: Tnf, FAM-CAG GTC TAC TTT 
GGA GTC ATT GCT C-BHQ1; Tnfrsf1a, FAM-CAC 
CGT GTC CTT GTC AGC-BHQ1; Gapdh, FAM-AGA 
CAA CCT GGT CCT CAG TGT-BHQ1; Sdha, FAM-
CCT GCG GCT TTC ACT TCT CT-BHQ1. Forward 
and reverse primers were used at a concentration of 
150 nM each and dual-labeled probes were used at a 
concentration of 300 nM. PCR was performed using 
the Mx3000P platform (Agilent, Berkshire, UK) using 
the following conditions: 45 cycles of 95°C for 12 s and 
60°C for 35 s. Standard curves were generated in every 
96-well plate, for each cDNA for every real-time PCR 
run, using serial threefold dilutions of reverse tran-
scribed spleen total RNA (Ambion, Paisley, UK). Four 
separate dissections were performed.
Statistics
Statistical comparisons for normally distributed data 
were performed by independent Student’s t-test or 
one-way ANOVA followed by Dunnet’s post hoc test 
and for non parametric data the Mann–Whitney test or 
one-way ANOVA Kruskal–Wallis followed by Dunn’s 
post hoc test as indicated.
RESULTS
Sympathetic Innervation of SCG Targets 
in Mice with Null Mutations in the Tnf 
and Tnfrsf1a Genes
We have previously reported that the sympathetic in-
nervation of three tissues innervated by the SCG, the 
iris, submandibular salivary gland, and nasal turbinate 
tissue is markedly reduced in both TNF-deficient and 
TNFR1-deficient mice compared with wild-type litter-
mates (Kisiswa et al., 2013). To extend this analysis, we 
examined additional tissues innervated by the SCG in 
the current study. We used tyrosine hydroxylase (TH) 
staining in whole mount tissue preparations (Kisiswa et 
al., 2013) to visualize sympathetic fibers in mice that 
were heterozygous or homozygous for null mutations in 
the Tnf gene (Korner et al., 1997), null mutations in the 
Tnfrsf1a gene (Pfeffer et al., 1993), and wild-type lit-
termates. We carried out this analysis at P10, which is 
after the period of development during which TNFR1-
activated TNF reverse signaling enhances SCG axon 
growth in vitro and is at a stage in vivo when sympa-
thetic innervation has become established (Kisiswa et 
al., 2013). All analysis was done blind.
The additional SCG targets examined were the pi-
neal gland and the trachea. The latter tissue is of par-
ticular interest because it is the only tissue in which 
NGF plays no role in promoting sympathetic fiber 
ramification during development (Glebova and Ginty, 
2004). TH-stained whole mount preparations revealed 
clear reductions in the ramification of sympathetic fi-
bers within both tissues in TNF-deficient and TNFR1-
deficient mice compared with wild-type littermates. 
Representative images of both tissues in Tnf−/− and 
Tnf+/+ littermates and in Tnfrsf1a−/− and Tnfrsf1a+/+ 
littermates are shown in Fig. 1. Using a stereologi-
cal method to estimate the extent of the growth and 
branching of sympathetic fibers within these tissues, 
we found highly significant decreases in Tnf−/− mice 
compared with Tnf+/+ littermates and Tnfrsf1a−/− 
mice compared with Tnfrsf1a+/+ littermates (Fig. 2). 
There were also significant reductions in Tnf+/− and 
Tnfrsf1a+/− mice in the pineal gland (Fig. 2A,B) and a 
significant reduction in the trachea of Tnfrsf1a+/− mice 
(Fig. 2D), suggesting gene dosage effects.
Sympathetic Innervation of PVG Targets 
in Mice with Null Mutations in the 
Tnf and Tnfrsf1a Genes
We examined two organs that receive their sympathetic 
innervation predominantly from PVG neurons, the 
stomach, and spleen. The stomach receives its sympa-
thetic innervation predominantly from the coeliac and 
superior mesenteric ganglia and has smaller contribu-
tions from the splanchnic ganglia and the lower thoracic 
paravertebral sympathetic chain. The spleen receives 
its sympathetic innervation predominantly from the 
splanchnic ganglia and has smaller contributions from 
the inferior mesenteric and lower thoracic paraverte-
bral sympathetic chain (Chevendra and Weaver, 1991; 
Trudrung et al., 1994; Quinson et al., 2001).
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Figure 1 Images of reduced sympathetic innervation in the pineal gland and trachea of mice pos-
sessing null mutations in the Tnf and Tnfrsf1a genes. Representative images of P10 whole mount 
preparations of the pineal gland (A, B) and trachea (C, D) of P10 Tnf−/−and Tnf+/+ littermates (A, 
C) and P10 Tnfrsf1a−/−and Tnfrsf1a+/+ littermates (B, D) stained with anti-TH. Scale bars, 100 μm.
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In addition to using TH staining in whole mount 
tissue preparations to visualize sympathetic fibers at 
P10 (Kisiswa et al., 2013), we also used TH staining 
in iDISCO (Renier et al., 2014). For technical reasons, 
the latter analysis was carried out at P6, which is still 
after sympathetic innervation has become established 
(Glebova and Ginty, 2004). As with analysis of SCG 
targets, all quantification was done blind.
There was no obvious difference in the anatomical 
disposition of sympathetic fibers in the stomach of 
Tnf−/− and Tnfrsf1a−/− mice compared with Tnf+/+ and 
Tnfrsf1a+/+ littermates. Representative whole mount 
and iDISCO images of the stomach of Tnf−/− and Tnf+/+ 
littermates and Tnfrsf1a−/− and Tnfrsf1a+/+ littermates 
are shown in Fig. 3A–D. Quantification of the rela-
tive length per unit area of TH-positive fibers in whole 
mount preparations (Fig. 4A,B) and TH-intensity in 
iDISCO preparations (Fig. 4C,D) confirmed that there 
was no significant reduction in sympathetic fiber 
branching within the stomach between Tnf−/− and 
Tnf+/+ littermates (Fig. 4A,C) and between Tnfrsf1a−/− 
and Tnfrsf1a+/+ littermates (Fig. 4B,D).
There was also no obvious difference in the anatom-
ical disposition of sympathetic fibers in the spleen of 
Tnf−/− and Tnfrsf1a−/− mice compared with Tnf+/+ and 
Tnfrsf1a+/+ littermates. Representative whole mount 
and iDISCO images of the spleen of Tnf−/− and Tnf+/+ 
littermates and Tnfrsf1a−/− and Tnfrsf1a+/+ littermates 
are shown in Fig. 3E–H. Quantification of the rela-
tive length per unit area of TH-positive fibers in whole 
mount preparations (Fig. 4E,F) and TH-intensity 
in iDISCO preparations (Fig. 4G,H) confirmed that 
there was no significant reduction in sympathetic fiber 
branching within the spleen between Tnf−/− and Tnf+/+ 
littermates (Fig. 4E,G) and between Tnfrsf1a−/− and 
Tnfrsf1a+/+ littermates (Fig. 4F,H). There were, how-
ever, small statistically significant increases in the in-
nervation of the spleen in mice that were heterozygous 
and homozygous for a null mutation in the Tnfrsf1a 
gene quantified in both whole mount and iDISCO 
preparations (Fig. 4F,H).
Differences in the Response of SCG and 
PVG Neurons to TNFR1-Activated TNF 
Reverse Signaling
To determine if the different effects of Tnf and 
Tnfrsf1a deletion on the innervation of SCG and PVG 
targets were due to differences in the response of SCG 
and PVG neurons to TNFR1-activated TNF reverse 
signaling we cultured postnatal SCG and PVG neu-
rons at low density in dissociated cultures. NGF was 
included in these cultures to sustain neuronal survival 
and the neurons were treated with and without a di-
valent TNFR1-Fc chimera (in which the extracellular 
domains of two TNFR1 molecules are linked to the 
Fc part of a human IgG1 antibody) to activate TNF-
mediated reverse signaling (Kisiswa et al., 2013). We 
studied the PVG neurons of the coeliac and superior 
Figure 2 Quantification of reduced sympathetic innerva-
tion in the pineal gland and trachea of mice possessing null 
mutations in the Tnf and Tnfrsf1a genes. Relative length 
per unit area of sympathetic fibers in the pineal gland (A, 
B) and trachea (C, D) of P10 whole mount preparations of 
wild-type mice and littermates that are heterozygous or 
homozygous for null mutations of the Tnf gene (A, C) and 
Tnfrsf1a gene (B, D). Data are expressed as a percentage 
of wild type. Mean ± s.e.m. of data from the pineal gland 
of six Tnf+/+, seven Tnf
+/−, eight Tnf−/−, six Tnfrsf1a+/+, six 
Tnfrsf1a+/−, seven Tnfrsf1a−/− animals and from the trachea 
of five Tnf+/+, six Tnf
+/−, six Tnf−/−, five Tnfrsf1a+/+, seven 
Tnfrsf1a+/−, six Tnfrsf1a−/− animals (*P < 0.05, **P < 0.01 
and ***P < 0.001 compared to wild type,  one-way ANOVA 
Kruskal–Wallis, Dunn’s post hoc test).
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mesenteric ganglia, because these ganglia can be most 
easily dissected from neonates.
The axon growth-promoting action of NGF on P0 
SCG neurons was enhanced by TNFR1-Fc, as shown 
by Sholl analysis in P0 cultures (Fig. 5A). In contrast, 
TNFR1-Fc failed to enhance axon growth and branch-
ing from P0 PVG neurons (Fig. 5B). Sholl analysis 
carried out at P5 revealed a similar trend (not shown). 
Representative images of SCG and PVG neurons 
grown with and without TNFR1-Fc are shown (Fig. 
5C). These findings suggest that TNFR1-activated 
TNF-mediated reverse signaling is able to enhance 
axon growth from postnatal SCG neurons but not from 
postnatal PVG neurons.
TNFR2-Fc Does Not Influence 
Axon Growth from Either SCG or 
PVG Neurons
Because TNFR2 has been shown to elicit TNF-
mediated reverse signaling in the immune system (Sun 
and Fink, 2007), we investigated whether TNFR2-
activated TNF reverse signaling might differentially 
influence axon growth from SCG and PVG neurons. 
TNFR2-Fc did not significantly affect axon growth 
from either SCG or PVG neurons grown with NGF 
(Fig. 5D,E).
TNF Suppresses NGF-Promoted Growth 
from Both SCG and PVG Neurons
Soluble TNF is known to suppress NGF-promoted 
axon growth from cultured SCG neurons (Gutierrez 
and Davies, 2007). Because suppression of axon 
growth by TNF is not observed in TNFR1-deficient 
neurons (Kisiswa et al., 2013), it is likely that soluble 
TNF acts by a TNFR1-mediated forward signaling 
mechanism. To ascertain whether TNF has a com-
parable effect on NGF-promoted axon growth from 
PVG neurons, we compared the effect of TNF on 
NGF-promoted axon growth from SCG and PVG neu-
rons in low-density dissociated cultures at P0. TNF 
Figure 3 Images of sympathetic innervation of the stomach and spleen of mice possessing null 
mutations in the Tnf and Tnfrsf1a genes. Representative images of P10 whole-mount (A, C) and P6 
iDISCO (B, D) preparations of the stomach and of P10 whole-mount (E, G) and P6 iDISCO (F, H) 
preparations of the spleen of Tnf−/− and Tnf+/+ littermates (A, B, E, F) and Tnfrsf1a−/−and Tnfrsf1a+/+ 
littermates (C, D, G, H) stained with anti-TH. Scale bars, 200 μm.
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suppressed NGF-promoted axon growth from both 
SCG and PVG neurons. This was evident in Sholl plots 
of both kinds of neurons (Fig. 6A). Quantification of 
the total length and number of branch points in the 
axon arbors of SCG and PVG neurons revealed statis-
tically significant decreases in length and branching 
in the presence of TNF in both kinds of neurons (Fig. 
6B). Sholl analysis carried out at P5 revealed a simi-
lar trend (not shown). The appearances of typical SCG 
and PVG neurons grown with and without TNF are 
shown (Fig. 6C). These findings suggest that TNF 
suppresses NGF-promoted axon growth from SCG 
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neurons and PVG neurons grown in dissociated cul-
ture in which both the soma and axons of these neu-
rons are exposed to TNF.
TNF Suppresses NGF-Promoted 
Growth When Applied to Different 
Regions of SCG and PVG Neurons in 
Compartment Culture
Although TNF suppressed NGF-promoted axon 
growth from both SCG and PVG neurons when the 
axons and cell soma of these neurons were exposed 
to TNF in vitro, because target-derived TNF acts only 
on axons in vivo, we investigated whether SCG and 
PVG neurons differ in their response to TNF when 
treatment is restricted to axons. To do this, we grew 
the SCG and PVG neurons in compartment cultures 
in which the cell soma and axons are separated by a 
barrier (Fig. 7A). In these experiments, we seeded ei-
ther P0 SCG or P0 PVG neurons into one compart-
ment (the soma compartment) of a two-compartment 
device that contained NGF in both compartments to 
sustain neuronal survival and encourage axon growth 
from the soma compartment into the axon compart-
ment. TNF was added either to the soma compartment 
or to the axon compartment or to neither compart-
ment. After 18-h incubation, we labeled the axons in 
the axon compartment with the fluorescent vital dye 
calcein-AM, which also retrogradely labeled cell bod-
ies of neurons that projected axons into the axon com-
partment, allowing for normalization of axon length 
against cell body number. A stereological method was 
used to quantify the extent of axon growth in the axon 
compartment relative to the number of neurons pro-
jecting axons into this compartment.
These compartment cultures revealed a clear differ-
ence in the response of SCG and PVG neurons to TNF. 
Whereas exposure of the cell soma of SCG neurons to 
TNF significantly reduced axon growth in the axon 
compartment, exposure of SCG axons to TNF did 
not significantly affect axon growth (Fig. 7B,C). In 
marked contrast, whereas exposure of the cell soma of 
PVG neurons to TNF did not significantly affect axon 
growth in the axon compartment, exposure of PVG 
axons to TNF significantly reduced axon growth (Fig. 
7B,C). These results reveal that TNF significantly 
suppresses axon growth when applied to different 
parts of SCG and PVG neurons.
Although TNFR1-Fc did not affect PVG axon 
growth in vitro, we investigated the possibility of it 
exerting effects when applied to different regions of 
PVG neurons. As previously reported (Kisiswa et al, 
2013), TNFR1-Fc increased SCG axon length when 
applied to axons and not somas (Fig. 7D). On the other 
hand, in three independent experiments. TNFR1-Fc 
did not significantly affect axon growth from PVG 
neurons when applied to either the soma or axon com-
partments (Fig. 7D).
Expression of TNF and TNFR1 in 
SCG and PVG Neurons
A potential explanation for the differences in the 
response of SCG and PVG neurons to TNF in com-
partment cultures might be related to differences in 
the expression and/or the distribution of TNFR1 and 
TNF on these neurons. It has been reported that the 
TNFR1 expression is restricted to the cell body of 
SCG neurons and is not detectable on the axons of 
these neurons, accounting for the lack of response of 
SCG neurons to TNF applied to their axons (Kisiswa 
et al., 2013). To ascertain whether TNFR1 expression 
on PVG neurons has a different spatial distribution 
that could account for the response of these neurons 
to TNF applied to their axons, we used immunocy-
tochemistry to study the expression of TNFR1 on 
Figure 4 Quantification of sympathetic innervation of the stomach and spleen of mice possessing 
null mutations in the Tnf and Tnfrsf1a genes. Relative length per unit area of TH-positive fibers in 
stomach whole mounts (A, B) and relative TH immunofluorescence intensity in stomach iDISCO 
preparations (C, D) of wild type mice and littermates that are heterozygous or homozygous for null 
mutations of the Tnf gene (A, C) and Tnfrsf1a gene (B, D). Relative length per unit area of TH-pos-
itive fibers in spleen whole mounts (E, F) and relative TH immunofluorescence intensity in spleen 
iDISCO preparations (G, H) of wild-type mice and littermates that are heterozygous or homozygous 
for null mutations of the Tnf gene (E, G) and Tnfrsf1a gene (F, H). Data are expressed as a percent-
age of wild type. Mean ± s.e.m. of data from the stomach of six Tnf+/+, siz Tnf
+/−, six Tnf−/−, eight 
Tnfrsf1a+/+, eight Tnfrsf1a
+/−, five Tnfrsf1a−/− animals and from the spleen of six Tnf+/+, eight Tnf
+/−, 
seven Tnf−/−, eight Tnfrsf1a+/+, eight Tnfrsf1a
+/−, six Tnfrsf1a−/− animals in whole mount preparations. 
Mean ± s.e.m. of data from the stomach of eight Tnf+/+, eight Tnf
+/−, eight Tnf−/−, nine Tnfrsf1a+/+, 
seven Tnfrsf1a+/−, eight Tnfrsf1a−/− animals and from the spleen of eight Tnf+/+, eight Tnf
+/−, nine 
Tnf−/−, nine Tnfrsf1a+/+, nine Tnfrsf1a
+/−, six Tnfrsf1a−/− animals in iDISCO preparations. *P < 0.05 
and NS = not significant, compared to wild type, one-way ANOVA for iDISCO stomach and Krus-
kal–Wallis, Dunn’s post hoc test all the rest.
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Figure 5 Differences in the response of cultured SCG and PVG neurons to TNFR1-activated 
TNF-mediated reverse signaling. Sholl plots of P0 SCG (A) and PVG (B) neurons cultured for 18 h 
with either 10 ng/ml NGF or NGF plus 30 ng/ml TNFR1-Fc. Mean ± s.e.m. of data of >150 neurons 
per condition combined from three separate experiments of each type. (C) Images of representa-
tive P0 SCG neurons and PVG neurons grown for 18 h with NGF with or without TNFR1-Fc as 
indicated. Scale bar, 50 μm. Sholl plots of P0 SCG (D) and PVG (E) neurons cultured for 18 h with 
either 10 ng/ml NGF or NGF plus 50 ng/ml TNFR2-Fc. Mean ± s.e.m. of data of >150 neurons per 
condition combined from three separate experiments of each type. [Colour figure can be viewed at 
wileyonlinelibrary.com]
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Figure 6 TNF suppresses NGF-promoted axon growth from both SCG and PVG neurons in dis-
sociated cultures. Sholl plots (A) and quantification of number of branch points and the total axon 
length (B) of the arbors of P0 SCG and PVG neurons cultured for 18 h with either 10 ng/ml NGF 
or NGF plus 50 ng/ml TNF. Mean ± s.e.m. of data of >150 neurons per condition combined from 
three separate experiments of each type (*** indicates P < 0.001, ** indicates P < 0.01, * indicates 
P < 0.05, Mann–Whitney). (C) Images of representative SCG neurons and PVG neurons grown for 
18 h with NGF with or without TNF as indicated. Scale bar, 50 μm. [Colour figure can be viewed at 
wileyonlinelibrary.com]
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dissociated cultured neurons. To label both the cell 
soma and axons of the neurons, the cultures were dou-
ble labeled with βIII-tubulin antibodies. As previously 
reported, TNFR1 immunoreactivity was restricted to 
the cell soma of SCG neurons and was not evident 
on their axons (Fig. 8A). In contrast, in PVG cultures 
set up and processed in parallel, TNFR1 immunore-
activity was observed along the axons as well as the 
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cell soma (Fig. 8A). This difference in the distribu-
tion of TNFR1 between SCG and PVG neurons is the 
likely explanation of the ability of the PVG neurons, 
but not SCG neurons, to respond to TNF applied to 
their axons. This in turn implies that PVG neurons, 
but not SCG neurons, are capable of responding to 
target-derived TNF in vivo.
Like TNFR1 immunoreactivity, TNF immunore-
activity was evident on both SCG and PVG neurons. 
However, in contrast to TNFR1 immunoreactivity, 
TNF immunoreactivity was observed on the cell soma 
and the axons of both SCG and PVG neurons (Fig. 
8B). Thus, differences in the expression of TNF are 
unlikely to account for the lack of a TNF-mediated 
axon growth response of PVG neurons to TNFR1. To 
demonstrate the specificity of the antibodies used in 
the above studies, we carried out immunocytochem-
istry on cultures established from knockout animals. 
TNF immunoreactivity was eliminated in cultures 
established from Tnf−/− mice and TNFR1 immunore-
activity was eliminated in cultures established from 
Tnfrsf1a−/−mice (not shown).
We also studied and compared TNFR2 immuno-
reactivity in cultured SCG and PVG neurons using 
a specific anti-TNFR2 antibody. As previously re-
ported, TNFR2 immunoreactivity was low com-
pared with TNF and TNFR1 immunoreactivity in 
SCG neurons (Kisiswa et al., 2013). Using identical 
staining protocols and the same fluorescence mi-
croscope settings, TNFR2 immunoreactivity was 
markedly lower at cell soma compared with TNF 
and TNFR1 immunoreactivity and TNFR2 immu-
noreactivity was only evident along the axons of 
a subset of SCG neurons (Fig. 8C). A similar low 
level of TNFR2 immunoreactivity was evident in 
PVG neuron soma and TNFR2 immunoreactivity 
was evident along the axons of a similar subset of 
PVG neurons (Fig. 8C). The similar low level and 
distribution of TNFR2 immunoreactivity in SCG 
and PVG neurons suggests that differences in the 
expression of TNFR2 is unlikely to contribute to the 
differences observed between SCG and PVG neu-
rons in vivo and in vitro.
Expression of TNF and TNFR1 
Transcripts in the SCG, PVG, and 
Their Targets
To assess the expression of transcripts encoding TNF 
and TNFR1 in the SCG and PVG, we used reverse 
transcription qPCR to quantify the levels of these 
transcripts relative to the levels of reference mRNAs 
encoding the house keeping enzymes glyceraldehyde 
phosphate dehydrogenase and succinate dehydroge-
nase. Both kinds of ganglia expressed transcripts en-
coding these proteins (Fig. 9A,B).
To determine whether transcripts encoding TNF 
and TNFR1 are present in SCG and PVG targets and 
to compare the relative levels of these transcripts in 
targets and ganglia, we used qPCR to quantify the lev-
els of these transcripts relative to reference mRNAs in 
two tissues: the submandibular gland (SMG) and the 
spleen. Tnf and Tnfrsf1a mRNAs were present in both 
tissues, but at much higher levels than in the innervat-
ing ganglia. The level of Tnf mRNA was about 20-fold 
higher in tissue than in the ganglia (Fig. 9C) and the 
level of Tnfrsf1a mRNA was about fivefold higher in 
tissue then in the ganglia (Fig. 9D). The level of Tnf 
mRNA was significantly higher in the spleen than in 
the SMG (Fig. 9C) and the levels of Tnfrsf1a mRNA 
were not significantly different in these tissues. These 
findings imply that TNF and TNFR1 are synthesized 
in both tissues where they are potentially able to act on 
the innervating axons.
Figure 7 TNF suppresses NGF-promoted growth when applied to PVG axons, but not SCG axons. 
(A) Schematic illustration of the two-chamber microfluidic device. (B) Bar charts of mean axon 
length of either P0 SCG or P0 PVG neurons projecting axons into the axon compartment quantified 
after 18-h incubation. Both compartments contained 10 ng/ml NGF plus caspase inhibitor and the 
compartments either received no additional treatment (control) or 50 ng/ml TNF was added to either 
the soma or axon compartment. The data represent the mean ± s.e.m of 3 independent experiments 
(*** indicates P < 0.001, * indicates P < 0.05, and NS indicates not significant, statistical compari-
son with control, one-way ANOVA Kruskal–Wallis, Dunn’s post hoc)  (C) Representative images of 
calcein-AM labeled neurons cultured under the experimental conditions labeled. Scale bar, 100 μm. 
(D) Bar charts of mean axon length of either P0 SCG or P0 PVG neurons projecting axons into the 
axon compartment quantified after 18 h incubation. Both compartments contained 10 ng/ml NGF 
plus caspase inhibitor and the compartments either received no additional treatment (control) or 
50 ng/ml TNFR1-Fc was added to either the soma or axon compartment. The data represent the 
mean ± s.e.m of 1 experiment for SCG neurons and three independent experiments for PVG neurons 
(*** indicates P < 0.001, * indicates P < 0.05, and NS indicates not significant, statistical compari-
son with control, one-way ANOVA Kruskal–Wallis, Dunn’s post hoc). [Colour figure can be viewed 
at wileyonlinelibrary.com]
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DISCUSSION
We have used in vivo and in vitro approaches to assess 
the contribution of TNF and TNFR1 to the establish-
ment of sympathetic innervation of different tissues in 
developing mice and to clarify the underlying signal-
ing mechanisms. Our in vivo studies of the phenotypes 
of TNF-deficient and TNFR1-deficient mice have 
revealed significant decreases in the sympathetic in-
nervation density of SCG targets compared with wild-
type mice but either no change or hyperinnervation 
of PVG targets. Our in vitro studies suggest that these 
phenotypic differences in innervation are related in 
part to differences in the specific growth responses of 
Figure 8 Immunolocalization of TNF, TNFR1, and TNFR2 on SCG and PVG neurons. Representa-
tive photomicrographs of P0 SCG neurons and PVG neurons double labeled with either anti-TNFR1 
and anti-βIII-tubulin antibodies (A) or anti-TNF and anti-βIII-tubulin antibodies (B) or anti-TNFR2 
and anti-βIII-tubulin antibodies (C) after 24-h culture in NGF-supplemented medium. The prepara-
tions were also counterstained with the nuclear marker, DAPI. Scale bars, 10 μm. [Colour figure can 
be viewed at wileyonlinelibrary.com]
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SCG and PVG neurons to TNF and TNFR1 applied 
to their axons. This implies that anatomically distinct 
populations of sympathetic neurons differ in their ca-
pacity to respond to target-activated TNF forward and 
reverse signaling.
Quantification of sympathetic innervation in the 
pineal gland and trachea of Tnf−/− and Tnfrsf1a−/− 
postnatal mice revealed highly significant 20%–30% 
reductions compared with wild-type littermates. 
Highly significant reductions in sympathetic innerva-
tion of similar magnitudes (20%–50% compared with 
wild-type littermates) were also reported in three other 
SCG targets, the submandibular salivary gland, nasal 
turbinates, and iris, in Tnf−/− and Tnfrsf1a−/− postnatal 
mice (Kisiswa et al., 2013). Significant intermediate 
reductions in sympathetic innervation were observed 
in most of these tissues and in the pineal gland and 
trachea of heterozygous mice, which is consistent 
with gene dose effects in all tissues. Taken together, 
our current findings and previously reported find-
ings suggest that TNF and TNFR1 play an important 
role in establishing the sympathetic innervation of all 
SCG targets examined. These in vivo studies together 
with the previously reported expression of TNF, but 
not TNFR1, along SCG axons and the expression 
of TNFR1 by SCG target field cells (Kisiswa et al., 
2013) suggest that TNFR1 expressed in target tissue 
activates TNF reverse signaling in axons in the tar-
get tissue. TNF reverse signaling in turn promotes 
axon growth by triggering Ca2+ influx via T-type Ca2+ 
channels, which leads to activation of PKC and ERK 
(Kisiswa et al., 2013, 2017).
Our current demonstration of the importance of 
TNF and TNFR1 in the establishment of tracheal 
sympathetic innervation is especially intriguing 
because the trachea is the only structure in which 
Figure 9 Relative expression of Tnf and Tnfrsf1a mRNAs in SCG and PVG and their target organs. 
Bar charts of the levels of Tnf mRNA (A) and Tnfrsf1a mRNA (B) in P0 SCG and P0 PVG. Bar 
charts of the levels of Tnf mRNA (C) and Tnfrsf1a mRNA (D) in P0 submandibular gland (SMG) 
and P0 spleen. Mean ± s.e.m of data from four separate samples (arbitrary values, ** indicates 
P < 0.01, t-test).
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sympathetic fibers grow and branch independently 
of NGF. Mice lacking NGF and BAX, a key protein 
required for apoptosis, retain sympathetic neurons 
but have reduced or absent sympathetic innervation 
in all tissues except the trachea (Glebova and Ginty, 
2004). This raised the question of the factor(s) that 
promote the growth and ramification of sympathetic 
fibers in this tissue. The substantial significant re-
ductions in sympathetic innervation in the trachea 
of Tnf−/− and Tnfrsf1a−/− mice suggest that TNF and 
TNFR1, probably by a reverse signaling mechanism, 
make a significant contribution to the establishment 
of the sympathetic innervation of this tissue. Tracheal 
sympathetic innervation is not, however, eliminated in 
Tnf−/− and Tnfrsf1a−/− mice, suggesting that additional 
factors are involved. The demonstration that tracheal 
sympathetic innervation is significantly reduced to a 
small extent in mice lacking GDF5 suggests that this 
factor also makes a contribution to establishing the 
sympathetic innervation of this tissue (O’Keeffe et al., 
2016).
In marked contrast to all SCG targets examined, 
there was either no significant decrease in the sympa-
thetic innervation of the spleen and stomach of Tnf−/− 
and Tnfrsf1a−/− mice, tissues that are predominantly 
innervated by PVG neurons, or small statistically sig-
nificant increases in the innervation of the spleen in 
Tnfrsf1a−/− mice quantified in both whole mount and 
iDISCO preparations. An increase in sympathetic in-
nervation was also observed in Tnf−/− mice in whole 
mount preparations, although this did not reach sta-
tistical significance. This implies that TNFR1 at least 
plays a role in suppressing the ramification of sympa-
thetic axons in the spleen. We are confident of these 
results because large numbers of mutant and wild-type 
mice were examined blind. Moreover, we visualized 
sympathetic fibers using two methods, whole mount 
and iDISCO, and studied innervation at two ages, P6 
and P10. While there is some difference in the mean in-
crease in innervation of the spleen in Tnfrsf1a−/− mice 
compared with Tnfrsf1a+/+ littermates in iDISCO and 
whole mount preparations, the statistical significance 
of the increase is similar in both cases. Although it is 
possible that this difference could be related to the dif-
ferent ages at which analysis was undertaken, sympa-
thetic fibers first reach their targets during early fetal 
development and have ramified extensively in their 
target tissues by P6 and P10.
The marked difference between the SCG and 
PVG targets observed in Tnf−/− and Tnfrsf1a−/− mice 
appears to be related to intrinsic differences in the 
response of SCG and PVG neurons to TNFR1 and 
TNF. First, while TNFR1-Fc significantly enhanced 
NGF-promoted axon growth from cultured postnatal 
SCG neurons, TNFR1-Fc failed to enhance NGF-
promoted axon growth from PVG neurons of the 
coeliac and superior mesenteric ganglia. These dif-
ferences in the response of SCG and PVG neurons 
to TNFR1-Fc are not simply due to differences in 
expression of the reverse signaling receptor. TNF 
is expressed along the axons of both SCG and PVG 
axons. Moreover, it is likely that PVG axons are 
exposed to TNFR1 in vivo, as this is expressed in 
PVG targets. It will be interesting in future work to 
ascertain which step or steps in the signaling cas-
cade leading from TNF activation to axon growth 
is blocked in PVG neurons. Second, while TNF 
suppresses NGF-promoted axon growth from both 
SCG and PVG neurons grown in dissociated culture 
in which both axons and cell soma are exposed to 
TNF, TNF only suppresses axon growth from PVG 
neurons, not SCG neurons, when axons are exposed 
to TNF in compartment cultures. This difference 
in the response of PVG and SCG neurons in com-
partment cultures to the growth inhibitory actions 
of TNF appears to be related to the distribution of 
TNFR1, the forward signaling receptor that medi-
ates this response, on the neurons. Whereas TNFR1 
expression is restricted to the cell soma of SCG neu-
rons, TNFR1 is expressed both at the cell soma and 
along the axons of PVG neurons. Thus, while TNF 
is expressed in the target tissues of both SCG and 
PVG neurons, only PVG neurons are capable of re-
sponding to target-derived TNF. These intriguing 
findings raise several interesting questions for fu-
ture research. For example, how is TNFR1 expres-
sion spatially restricted on SCG neurons and is the 
expression of TNFR1 on the soma of SCG neurons 
physiologically relevant?
Although previous work has shown that the reduc-
tion in NGF-promoted axon growth promoted by TNF 
is mediated by TNFR1 (Kisiswa et al., 2013), TNF re-
verse signaling can be activated by either TNFR1 or 
TNFR2 in the immune system (Sun and Fink, 2007). 
Two observations, however, suggest that TNFR2 does 
not contribute to the difference between SCG and PVG 
neurons reported in our study. First, TNFR2 is simi-
larly and weakly expressed in SCG and PVG neurons 
compared with TNF and TNFR1. Second, TNFR2-Fc 
does not affect neurite outgrowth from either SCG or 
PVG neurons.
The modulation of axon growth by TNF super-
family members, generally without affecting neuro-
nal survival, is becoming an emerging theme in the 
developing mammalian nervous system. In addition 
to the opposite effects of TNF forward and reverse 
signaling on sympathetic axon growth and target in-
nervation discussed here, TNF forward and reverse 
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signaling also exert opposite effects on the growth of 
dorsal root ganglion axons (Wheeler et al., 2014). In 
certain populations of neurons, GITRL and APRIL en-
hance axon growth (O’Keeffe et al., 2008; Osorio et 
al., 2014; McWilliams et al., 2017), whereas RANKL 
and LIGHT suppress the axon growth-promoting ac-
tions of neurotrophins (Gavalda et al., 2009; Gutierrez 
et al., 2013). Reverse signaling mediated by CD40L 
(McWilliams et al., 2015) and TWEPRIL (Howard et 
al., 2018) have also been shown to be key physiological 
regulators of axon growth and tissue innervation in the 
PNS. Moreover, initial studies in the developing CNS 
have shown that CD40L-mediated reverse signaling is 
a major physiological regulator of dendrite growth and 
elaboration, having opposite effects on excitatory and 
inhibitory neurons (Carriba and Davies, 2017).
In summary, our work has revealed unsuspected 
complexities in the ways in which TNF and TNFR1 
contribute to the establishment of sympathetic in-
nervation of different tissues. Axon growth and 
ramification within different tissues is differentially 
modulated by TNFR1-mediated TNF activated 
forward signaling and by TNF-mediated TNFR1-
activated reverse signaling in the innervating neu-
rons. These differences are related to differences in 
the capacity of anatomically different populations 
of innervating sympathetic neurons to respond to 
TNFR1 and TNF, which in turn are due, in part, to 
differences in the cellular distribution of TNF and 
TNFR1 on responsive neurons.
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